A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

PHASE3CompletedINTERVENTIONAL
Enrollment

658

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

December 12, 2018

Study Completion Date

December 18, 2018

Conditions
Depressive Disorder, Major
Interventions
DRUG

Rapastinel

Rapastinel pre-filled syringes for weekly IV injections.

DRUG

Placebo

Placebo-matching rapastinel pre-filled syringes for weekly IV injections.

Trial Locations (66)

10128

The Medical Research Network, LLC, New York

10312

Richmond Behavioral Associates, Staten Island

18104

Lehigh Center for Clinical Research, Allentown

19063

Suburban Research Associates, Media

20850

CBH Health, Rockville

21208

Pharmasite Research, Inc, Baltimore

27609

Richard H. Weisler, MD, PA, Raleigh

29407

Carolina Clinical Trials, Inc., Charleston

29464

Coastal Carolina Research Center, Inc., Mt. Pleasant

30030

iResearch Atlanta, LLC, Decatur

30080

IRIS Research, Smyrna

32607

Sarkis Clinical Trials, Gainesville

32763

Medical Research Group of Central Florida, Orange City

32801

Clinical Neuroscience Solutions, Inc, Orlando

32839

Millenia Psychiatry & Research, Inc, Orlando

33012

Reliable Clinical Research, Hialeah

33030

Advanced Research Institute of Miami, Homestead

33183

International Research Associates, LLC, Miami

33319

Innovative Clinical Research, Inc, Lauderhill

34474

Sarkis Clinical Trials, Ocala

35294

University of Alabama at Birmingham, Birmingham

39232

Precise Research Centers, Flowood

43210

The Ohio State University Department of Psychiatry, Columbus

44125

Charak Clinical Research Center, Garfield Heights

45040

Lindner Center of Hope, Mason

Professional Psychiatric Services, Mason

45215

Patient Priority Clinical Site, LLC, Cincinnati

60048

Capstone Clinical Research, Libertyville

60169

Alexian Brothers Center for Psychiatric Research, Hoffman Estates

60640

Great Lakes Clinical Trials, Chicago

63132

Millennium Psychiatric Associates, Olivette

66208

Phoenix Medical Research, Prairie Village

67207

Heartland Research Associates, Wichita

70629

Lake Charles Clinical Trials, Lake Charles

71104

J Gary Booker, MD APMC, Shreveport

72211

Woodland International Research Group, Little Rock

72758

Woodland Research Northwest, Rogers

73112

Red River Medical Research Center, LLC, Oklahoma City

Sooner Clinical Research, Inc, Oklahoma City

73118

Paradigm Research Professionals, Oklahoma City

75243

Relaro Medical Trials, Dallas

77058

Earle Research, Houston

77090

Red Oak Psychiatry Associates, PA, Houston

77347

El Campo Clinical Trials, El Campo

77381

Family Psychiatry of The Wood, The Woodlands

78754

Community Clinical Research, Inc., Austin

78759

BioBehavioral Research of Austin, Austin

84106

PRA Health Sciences, Salt Lake City

85724

University of Arizona Department of Psychiatry, Tucson

90230

ProScience Research Group, Culver City

91206

Behavioral Research Specialists, LLC, Glendale

91945

Synergy Clinical Research Center of Escondido, Lemon Grove

92103

Artemis Institute for Clinical Research, San Diego

92108

PCSD Feighner Research, San Diego

92506

CITrials, Riverside

92804

California Pharmaceutical Research Institute, Inc, Anaheim

94607

Pacific Research Partners; LLC., Oakland

97210

Summit Research Network, Portland

98011

Pacific Institute of Medical Sciences, Bothell

98201

Eastside Therapeutic Resource, Everett

02131

Boston Clinical Trials, Boston

01844

ActivMed Practices & Research, Inc., Methuen

02740

BTC of New Bedford, New Bedford

02190

Coastal Research Associates, Weymouth

08002

Center for Emotional Fitness, Cherry Hill

08053

Pharmaceutical Research Associates Inc, Marlton

All Listed Sponsors
lead

Naurex, Inc, an affiliate of Allergan plc

INDUSTRY

NCT02943564 - A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02) | Biotech Hunter | Biotech Hunter